Health
newsGP – AstraZeneca’s lower efficacy has been questioned, but what about other considerations? – RACGP
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
News
Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.
The spotlight is on AstraZenecas candidate, co-developed with the University of Oxford, as Australia moves closer to its mid-February vaccine rollout.
As the US, UK and Europe continue to record thousands of daily new cases of COVID-19, it has been said time again that Australia is in an enviable position.The vaccine roadmap is expected to begin with…
-
Noosa News20 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News22 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General19 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win
-
Noosa News18 hours agoFranz Ferdinand: Australian Tour 2025